GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRY) » Definitions » Net Issuance of Debt

SPHRY (Starpharma Holdings) Net Issuance of Debt : $-2.68 Mil (TTM As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Starpharma Holdings Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Starpharma Holdings's net issuance of debt for the six months ended in Jun. 2024 was $0.52 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Jun. 2024 was $-2.68 Mil.

Starpharma Holdings Net Issuance of Debt Historical Data

The historical data trend for Starpharma Holdings's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Net Issuance of Debt Chart

Starpharma Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Net Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2.81 - -2.66

Starpharma Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.12 - - -3.20 0.52

Starpharma Holdings Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Starpharma Holdings Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRY) » Definitions » Net Issuance of Debt
Comparable Companies
ASX:ADO ASX:RAD ASX:CYP ASX:TYP ASX:ATX ASX:NOX ASX:PTX ASX:ILA ASX:NYR ASX:BTC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
SPHRF:USA PQ6:Germany SPL:Australia
Address
4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067
Website
https://www.starpharma.com
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.